Results 51 to 60 of about 154,768 (166)
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
This article reviews the use of fecal microbiota transplantation (FMT) to treat intestinal diseases like recurrent Clostridioides difficile infection (rCDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). It discusses FMT's efficacy, influencing factors such as donor selection, recipient characteristics, and treatment protocols ...
Shuna Hou +4 more
wiley +1 more source
Metagenomic biomarker discovery and explanation [PDF]
This study describes and validates a new method for metagenomic biomarker discovery by way of class comparison, tests of biological consistency and effect size estimation.
Garrett, Wendy S. +6 more
core +3 more sources
Intratumoral microbiota (IM) has emerged as a significant component of the previously thought sterile tumor microenvironment (TME), exerting diverse functions in tumorigenesis and immune modulation.
Jingwei Zheng, Hao Chen
doaj +1 more source
Evolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disorders [PDF]
Industrialized society currently faces a wide range of non-infectious, immune-related pandemics. These pandemics include a variety of autoimmune, inflammatory and allergic diseases that are often associated with common environmental triggers and with ...
Adler +133 more
core +1 more source
Cardiac Cachexia and the Associations to the Microbiome: State‐of‐the‐Science Review
ABSTRACT Background Cardiac cachexia is a late manifestation of advanced heart failure, with a 5%–15% prevalence. A diagnosis of cardiac cachexia is not simply another complication of heart failure; clinical consequences of cachexia are impaired physical function, fatigue, poor quality of life and independently associated with heart failure severity ...
Kelley M. Anderson +4 more
wiley +1 more source
Disruption of the gut microbiome as a risk factor for microbial infections [PDF]
The discovery that microorganisms can be etiologic agents of disease has driven clinical, research and public health efforts to reduce exposure to bacteria.
Khosravi, Arya, Mazmanian, Sarkis K.
core +1 more source
Regulatory T cells and their role in allergic disease
Abstract The incidence of allergic diseases has been rising over the past decades, and this troubling trend coincides with environmental changes such as shifts in diet and increased antibiotic use, both of which can impact our immune system. Allergic reactions occur when the immune system overreacts to normally harmless substances, and it is known that
Melanie L. Conrad +6 more
wiley +1 more source
A review of engraftment assessments following fecal microbiota transplant
Fecal Microbiota Transplant (FMT) is a treatment for recurrent Clostridium difficile infections and is being explored for other clinical applications, from alleviating digestive and neurological disorders, to restoring microbiomes impacted by cancer ...
Chloe Herman +11 more
doaj +1 more source
Clearance of vancomycin- resistant Enterococcus concomitant with administration of a microbiota -based drug targeted at recurrent Clostridium difficile infection [PDF]
Background. Vancomycin-resistant Enterococcus (VRE) is a major healthcare-associated pathogen and a well known complication among transplant and immunocompromised patients.
Dubberke, Erik R +6 more
core +2 more sources
IntroductionContusion type of traumatic brain injury (TBI) is a major cause of locomotor disability and mortality worldwide. While post-TBI deleterious consequences are influenced by gender and gut dysbiosis, the sex-specific importance of commensal gut ...
Tulasi Pasam, Manoj P. Dandekar
doaj +1 more source

